Successful Treatment of a Multidrug-Resistant Tuberculosis Patient with a Negative Xpert MTB/RIF Test for Rifampicin-Resistant Tuberculosis in Guizhou Province of China: A Case Report

The Xpert MTB/RIF (Xpert) assay recommended by the World Health Organization (WHO) can be used to simultaneously detect Mycobacterium tuberculosis complex (MTBC) and rifampicin (RIF) resistance associated mutations. However, if Xpert testing results are negative for RIF resistance because mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhao-Liang, Chen, Ling, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217305/
https://www.ncbi.nlm.nih.gov/pubmed/32440172
http://dx.doi.org/10.2147/IDR.S245219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217305/
https://www.ncbi.nlm.nih.gov/pubmed/32440172
http://dx.doi.org/10.2147/IDR.S245219

Ejemplares similares